RecruitingACTRN12613000976785

Prospective analysis of the nutritional status of chemoradiotherapy patients


Sponsor

Royal Darwin Hospital

Enrollment

50 participants

Start Date

Jul 15, 2013

Study Type

Observational

Conditions

Summary

The study aims to evaluate the nutritional status of chemo-radiotherapy patients. Who is it for? You may be eligible to join this study if you are aged 18 years or over and are undergoing curative intent chemo-radiotherapy at the Alan Walker Cancer Care Centre in Darwin, Northern Territory. Trial details All participants in this study will have their nutritional status assessed at baseline, first week of treatment, then final week of treatment, and finally at 1-month post treatment using the Patient Generated-Subjective Global Assessment. This is a validated malnutrition assessment tool for cancer patients. This study aims to baseline the nutritional status of chemo-radiotherapy patients undergoing treatment at the Alan Walker Cancer Care Centre (Darwin), identify contributors to nutritional deterioration and determine if there is a difference between Indigenous and non-Indigenous patients. This study will provide a prospective analysis of malnutrition and a clear insight of nutritional status of cancer patients. This study will be the first of its kind to address the nutritional status of cancer patients in Indigenous Australians.


Eligibility

Sex: Both males and femalesMin Age: 18 YearssMax Age: 100 Yearss

Plain Language Summary

Simplified for easier understanding

This study monitors the nutritional status of cancer patients receiving chemotherapy and radiotherapy (chemo-radiotherapy) at the Alan Walker Cancer Care Centre in Darwin, Northern Territory. Cancer treatment can make it very hard to eat properly, leading to malnutrition that can slow recovery and make treatment less effective. Researchers will assess each patient's nutritional status at the start of treatment, during the first and last week of treatment, and one month after finishing. This is also the first study to specifically look at nutritional differences between Indigenous and non-Indigenous Australian cancer patients. You may be eligible if: - You are 18 years of age or older - You are receiving curative-intent chemo-radiotherapy at the Alan Walker Cancer Care Centre (Darwin, NT) - You are able to speak basic English or have an interpreter available - You are male or female You may NOT be eligible if: - You are pregnant or breastfeeding - You do not speak English and no interpreter is available - Your treatment changes from combined chemo-radiotherapy to a single treatment type, or changes from curative to palliative intent Talk to your doctor about whether this trial might be right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

All eligible patients attending the Alan Cancer Care Centre will be consented for participation into this study. Each participant’s nutritional status will be assessed at baseline, first week of treat

All eligible patients attending the Alan Cancer Care Centre will be consented for participation into this study. Each participant’s nutritional status will be assessed at baseline, first week of treatment, then final week of treatment, and finally at 1-month post treatment using a validated malnutrition assessment tool, the Patient Generated-Subjective Global Assessment. The Patient Generated-Subjective Global Assessment is a validated malnutrition assessment tool for cancer patients.


Locations(1)

Royal Darwin Hospital - Tiwi

NT, Australia

View Full Details on ANZCTR

For the most up-to-date information, visit the official listing.

Visit

ACTRN12613000976785